dsp 4 has been researched along with Brain Inflammation in 3 studies
DSP 4: RN given refers to parent cpd
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iravani, MM | 1 |
| Sadeghian, M | 1 |
| Rose, S | 1 |
| Jenner, P | 1 |
| Heneka, MT | 2 |
| Gavrilyuk, V | 1 |
| Landreth, GE | 1 |
| O'Banion, MK | 2 |
| Weinberg, G | 2 |
| Feinstein, DL | 2 |
| Galea, E | 1 |
| Gavriluyk, V | 1 |
| Dumitrescu-Ozimek, L | 1 |
| Daeschner, J | 1 |
| Klockgether, T | 1 |
3 other studies available for dsp 4 and Brain Inflammation
| Article | Year |
|---|---|
Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell loss.
Topics: Adrenergic Agents; Adrenergic Neurons; Animals; Benzylamines; CD11b Antigen; Cell Count; Cell Death; | 2014 |
Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression.
Topics: Amyloid beta-Peptides; Animals; Benzylamines; Brain; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; | 2003 |
Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease.
Topics: Adjuvants, Immunologic; Adrenergic beta-Agonists; Alzheimer Disease; Amyloid beta-Peptides; Animals; | 2002 |